Triple Analysis: Pancreatic Cancer, Angiogenesis and Peptides

BioSeeker Group AB
January 7, 2013
3820 Pages - SKU: BIOS4940027
The Market for Personalized Gene Therapy Treatments for Cancer
12/23/2014 | published by: Kalorama Information
The Market for Personalized Gene Therapy Treatments for Cancer This report, The Market for Personalized Gene Therapy Treatments For Cancer provides an exhaustive review of the market potential for relatively new approach  |  read more...
USD 3,995
Global Cancer Biomarkers Market 2015-2019
1/14/2015 | published by: TechNavio - Infiniti Research Ltd.
Global Cancer Biomarkers Market 2015-2019 About Cancer Biomarkers Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly  |  read more...
USD 2,500
2015 German Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
1/12/2015 | published by: VPGMarketResearch.com
2015 German Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies 2015 German Cancer Diagnostics Market ; is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during  |  read more...
USD 6,800
2015 Spanish Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
1/12/2015 | published by: VPGMarketResearch.com
2015 Spanish Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies 2015 Spanish Cancer Diagnostics Market ; is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during  |  read more...
USD 6,800
2015 UK Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
1/12/2015 | published by: VPGMarketResearch.com
2015 UK Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies 2015 UK Cancer Diagnostics Market ; is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during  |  read more...
USD 6,800
2015 European Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
1/12/2015 | published by: VPGMarketResearch.com
2015 European Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing This new 970-page comprehensive five-country report from VPGMarketResearch.com is designed to help current  |  read more...
USD 19,700
Hematological Cancers Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Unmet needs across the hematological malignancies remain high, with most traditional therapies conferring low levels of specificity and high toxicity. There are today 485 companies plus partners developing 752 hematological cancer drugs in 1767 developmental projects  |  read more...
USD 8,996
HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Cancer cells are characterized by rapid proliferation and require adaptive metabolic responses to allow continued biosynthesis and cell growth in the setting of decreased oxygen (O(2)) and nutrient availability. The hypoxia-inducible factors (HIFs) are a  |  read more...
USD 6,746
TSLP Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine that play various roles in a broad spectrum of biological procedures. TSLP can be secreted by epithelial cells upon pathogen stimulation. TSLP can also activate dendritic cells,  |  read more...
USD 6,746
ID Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Inhibitor of DNA binding (ID) proteins are members of the helix-loop-helix (HLH) family of proteins which lack a DNA binding domain themselves but bind to other family members inhibiting their DNA binding capacity. This family  |  read more...
USD 2,246
 

SELECT A LICENSE

    Electronic Access
Single User Fulfilled by Publisher
  USD 5,175  
    Electronic Access
Global Site License Fulfilled By Publisher
  USD 12,937.50  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!